The Gastrointestinal Steering Committee (GISC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult gastrointestinal cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GISC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Cathy Eng, M.D., FACP
Vanderbilt University Ingram Cancer Center
Nashville, TN
Harvey J. Mamon, M.D., Ph.D.
Brigham and Women's Hospital
Boston, MA
Members
Carmen Allegra, M.D.
National Cancer Institute
Bethesda, MD
Rebecca Auer, M.D., M.Sc., FRCSC
The Ottawa Hospital Research Institute
Ottawa, ON, Canada
Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Jonathan Bleeker, M.D.
University of South Dakota Medical Center
Sioux Falls, SD
Kristen K. Ciombor, M.D., M.S.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Suzanne Dahlberg, Ph.D.
Boston Children's Hospital
Boston, MA
Anjelica Q. Davis
Fight Colorectal Cancer
Springfield, MO
Thomas J. George, Jr., M.D., FACP
University of Florida
Gainesville, FL
Sharlene Gill, M.D., M.P.H.
University of British Columbia
Vancouver, BC, Canada
Katherine Guthrie, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA
Theodore S. Hong, M.D.
Massachusetts General Hospital
Boston, MA
Chen Hu, Ph.D.
Johns Hopkins University School of Medicine
Baltimore, MD
Lisa A. Kachnic, M.D.
Columbia University Irving Medical Center
New York, NY
Hagen F. Kennecke, M.D., M.H.A., FRCPC
Oregon Health & Science University
Portland, OR
Elise Kohn, M.D.
National Cancer Institute
Bethesda, MD
Andrew Lowy, M.D., FACS
University of California San Diego Moores Cancer Center
San Diego, CA
Jeffrey Meyerhardt, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD
Christopher O'Callaghan, Ph.D., D.V.M.
Queen's University
Kingston, ON, Canada
Eileen O'Reilly, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Philip Philip, M.D., Ph.D., FRCP
Karmanos Cancer Institute
Detroit, MI
Laura Porter, M.D., FASCO
Patient Advocate
Cheverly, MD
Lewis R. Roberts, M.B., CH.B., Ph.D.
Mayo Clinic
Rochester, MN
Lawrence V. Rubinstein, Ph.D.
National Cancer Institute
Bethesda, MD
Qian Shi, Ph.D.
Mayo Clinic
Rochester, MN
Terence Z. Wong, M.D., Ph.D.
Duke University Medical Center
Durham, NC
Jen Jen Yeh, M.D.
University of North Carolina at Chapel Hill
Chapel Hill, NC
NCI CCCT Program Director
Laurie Shuman Moss, Ph.D.
laurie.shumanmoss@nih.gov